Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT05889182
PHASE3

A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-TNF Therapy

Sponsor: AbbVie

View on ClinicalTrials.gov

Summary

Hidradenitis suppurativa (HS) is an inflammatory skin disease that causes painful lesions in the axilla (underarm), inguinal (groin) and anogenital (anal/genital) regions. This study will assess how safe and effective upadacitinib is in treating adult and adolescent participants with moderate to severe HS who have failed to respond to or are intolerant of anti-tumor necrosis factor (TNF) therapy. Adverse events and change in disease activity will be assessed. Upadacitinib is an approved drug for ulcerative colitis, atopic dermatitis, rheumatoid arthritis, psoriatic arthritis, and axial spondylarthritis and is being developed for the treatment of HS. This study is "double-blinded", meaning that neither the trial participants nor the study doctors will know who will be given upadacitinib and who will be given placebo. This study is comprised of 3 periods. In Period 1, participants are randomized into 2 groups called treatment arms where each group receives a different treatment. There is a 1 in 2 chance that participants will be assigned to placebo. In Period 2, participants are placed into 6 different groups depending on their placement and results in Period 1. Period 3 is the long-term extension period where participants will continue treatment from Period 2. Approximately 1328 adult and adolescent participants diagnosed with HS will be enrolled in approximately 300 sites worldwide. Participants will receive oral tablets of upadacitinib or placebo once daily for 36 weeks in Period 1 and Period 2. Eligible participants from Period 1 and Period 2 will enter Period 3 and receive oral tablets of upadacitinib or placebo once daily for 68 weeks. Participants will be followed up for approximately 30 days. There may be higher treatment burden for participants in this trial compared to their standard of care. Participants will attend regular outpatient visits during the study. The effect of the treatment will be checked by medical assessments, checking for side effects and completing questionnaires.

Official title: A Phase 3, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate Efficacy and Safety of Upadacitinib in Adult and Adolescent Subjects With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-TNF Therapy

Key Details

Gender

All

Age Range

12 Years - Any

Study Type

INTERVENTIONAL

Enrollment

1328

Start Date

2023-06-21

Completion Date

2028-09

Last Updated

2026-08-20

Healthy Volunteers

No

Interventions

DRUG

Upadacitinib

Oral Tablets

DRUG

Placebo

Oral Tablets

Locations (285)

Cahaba Dermatology & Skin Health Center /ID# 254876

Birmingham, Alabama, United States

Peak Dermatology Aesthetics and Wellness Fountain Hills /ID# 272564

Fountain Hills, Arizona, United States

Medical Dermatology Specialists /ID# 254226

Phoenix, Arizona, United States

Mayo Clinic - Scottsdale /ID# 254388

Scottsdale, Arizona, United States

Banner University Medicine Dermatology /ID# 255853

Tucson, Arizona, United States

Clinical Trials Institute - Northwest Arkansas /ID# 254924

Fayetteville, Arkansas, United States

Burke Pharmaceutical Research /ID# 254238

Hot Springs, Arkansas, United States

Arkansas Research Trials /ID# 254233

North Little Rock, Arkansas, United States

NW Arkansas Clinical Trials Center /ID# 254311

Rogers, Arkansas, United States

Private Practice - Dr. Tooraj Raoof /ID# 254374

Encino, California, United States

Marvel Clinical Research /ID# 276228

Huntington Beach, California, United States

Dermatology Research Associates /ID# 254846

Los Angeles, California, United States

NorCal Clinical Research /ID# 274219

Rocklin, California, United States

Integrative Skin Science and Research /ID# 254930

Sacramento, California, United States

University of California Davis Health /ID# 254229

Sacramento, California, United States

Medderm Associates /ID# 253800

San Diego, California, United States

Clinical Trials Research Institute /ID# 254466

Thousand Oaks, California, United States

UConn Health Main /ID# 254507

Farmington, Connecticut, United States

Yale University School of Medicine /ID# 254586

New Haven, Connecticut, United States

Skin Care Research Boca Raton /ID# 253814

Boca Raton, Florida, United States

Apex Clinical Trials /ID# 255756

Brandon, Florida, United States

Florida Academic Dermatology Center /ID# 254011

Coral Gables, Florida, United States

Dermatology Associates of the Palm Beaches /ID# 275950

Delray Beach, Florida, United States

Skin Care Research - Hollywood /ID# 254508

Hollywood, Florida, United States

Life Clinical Trials - N State Rd - Margate /ID# 258613

Margate, Florida, United States

Skin Care Research - Tampa /ID# 256440

Tampa, Florida, United States

Advanced Clinical Research Institute - Tampa /ID# 253746

Tampa, Florida, United States

Avita Clinical Research /ID# 254471

Tampa, Florida, United States

Centricity Research - Columbus /ID# 255470

Columbus, Georgia, United States

Treasure Valley Medical Research /ID# 255208

Boise, Idaho, United States

DeNova Research /ID# 254372

Chicago, Illinois, United States

Northwestern University Feinberg School of Medicine /ID# 254503

Chicago, Illinois, United States

NorthShore University HealthSystem - Skokie /ID# 254389

Skokie, Illinois, United States

Dawes Fretzin /ID# 254390

Indianapolis, Indiana, United States

Options Research Group /ID# 254537

West Lafayette, Indiana, United States

U.S. Dermatology Partners Leawood /ID# 255838

Leawood, Kansas, United States

Equity Medical, LLC /ID# 271140

Bowling Green, Kentucky, United States

Massachusetts General Hospital /ID# 261093

Boston, Massachusetts, United States

Beth Israel Deaconess Medical Center /ID# 253811

Boston, Massachusetts, United States

Beacon Clinical Research, LLC /ID# 254419

Quincy, Massachusetts, United States

UMass Memorial Medical Center - Lake Avenue North /ID# 258839

Worcester, Massachusetts, United States

The Derm Institute Of West Michigan /ID# 275948

Caledonia, Michigan, United States

Hamzavi Dermatology - Canton /ID# 275856

Canton, Michigan, United States

Michigan Center for Medical Research - Clarkston /ID# 275860

Clarkston, Michigan, United States

Michigan Dermatology Institute /ID# 254468

Waterford, Michigan, United States

Cleaver Dermatology /ID# 254391

Kirksville, Missouri, United States

Dermatology and Skin Center of Lees Summit /ID# 257546

Lee's Summit, Missouri, United States

MediSearch Clinical Trials /ID# 254392

Saint Joseph, Missouri, United States

SSM Health Saint Louis University Hospital /ID# 256437

St Louis, Missouri, United States

Washington University School of Medicine - St. Louis /ID# 254506

St Louis, Missouri, United States

Vivida Dermatology- Flamingo /ID# 254227

Las Vegas, Nevada, United States

Las Vegas Dermatology /ID# 272421

Las Vegas, Nevada, United States

Skin Cancer and Dermatology Institute - Reno /ID# 254410

Reno, Nevada, United States

Empire Dermatology /ID# 276241

East Syracuse, New York, United States

NorthWell Health - Dermatology /ID# 254704

New Hyde Park, New York, United States

Schweiger Dermatology, P.C. /ID# 254232

New York, New York, United States

Private Practice - Dr. Bobby Buka /ID# 276371

New York, New York, United States

Onsite Clinical Solutions - Community House Rd - Charlotte /ID# 254854

Charlotte, North Carolina, United States

Duke University Medical Center /ID# 256898

Durham, North Carolina, United States

Apex Clinical Research Center, LLC /ID# 275956

Canton, Ohio, United States

ClinOhio Research Services /ID# 254851

Columbus, Ohio, United States

Dermatologists of Southwest Ohio, Inc /ID# 254297

Mason, Ohio, United States

Dermatology Partners - Medina /ID# 275939

Medina, Ohio, United States

Lynn Institute of Oklahoma City /ID# 253791

Oklahoma City, Oklahoma, United States

Oregon Health and Science University /ID# 254929

Portland, Oregon, United States

Penn State Milton S. Hershey Medical Center /ID# 254925

Hershey, Pennsylvania, United States

Paddington Testing Co., Inc. /ID# 254394

Philadelphia, Pennsylvania, United States

Clinical Research of Philadelphia, LLC /ID# 255308

Philadelphia, Pennsylvania, United States

Medical University of South Carolina /ID# 272569

Charleston, South Carolina, United States

Dermatology Associates of Knoxville /ID# 261082

Knoxville, Tennessee, United States

Arlington Research Center, Inc /ID# 253805

Arlington, Texas, United States

Bellaire Dermatology Associates /ID# 253797

Bellaire, Texas, United States

Dermatology Treatment and Research Center /ID# 253795

Dallas, Texas, United States

Modern Research Associates /ID# 253810

Dallas, Texas, United States

HRMD Research Dallas /ID# 255256

Dallas, Texas, United States

Dallas Fort Worth Clinical Research Associates (DFWCRA) /ID# 256438

Grapevine, Texas, United States

Suzanne Bruce and Associates-Houston /ID# 254228

Houston, Texas, United States

Texas Dermatology Research Center /ID# 254928

Plano, Texas, United States

Center for Clinical Studies Webster /ID# 254242

Webster, Texas, United States

Cope Family Medicine - Ogden Clinic /ID# 276227

Bountiful, Utah, United States

University of Utah - Murray /ID# 254452

Murray, Utah, United States

Springville Dermatology - Springville /ID# 276225

Springville, Utah, United States

University of Virginia - Dermatology /ID# 254535

Charlottesville, Virginia, United States

The Education & Research Foundation, Inc. /ID# 254852

Lynchburg, Virginia, United States

Virginia Clinical Research /ID# 254538

Norfolk, Virginia, United States

Frontier Dermatology /ID# 254554

Mill Creek, Washington, United States

Premier Clinical Research /ID# 254847

Spokane, Washington, United States

Hospital Universitario Austral /ID# 254904

Pilar, Buenos Aires, Argentina

Buenos Aires Skin /ID# 255299

Ciudad Autonoma de Buenos Aire, Buenos Aires F.D., Argentina

Instituto de Neumonologia y Dermatologia /ID# 254903

Ciudad Autonoma de Buenos Aire, Buenos Aires F.D., Argentina

Psoriahue Med Interdisciplinar /ID# 257202

Ciudad Autonoma de Buenos Aire, Buenos Aires F.D., Argentina

Consultorios Reumatologicos Pampa /ID# 255555

Ciudad Autonoma de Buenos Aire, Buenos Aires F.D., Argentina

Ciprec (Centro De Investigacion Y Prevencion Cardiovascular) - Barrio Norte /ID# 255474

Buenos Aires, Argentina

Hospital Italiano /ID# 254905

CABA, Argentina

Paratus Clinical Research Woden /ID# 254670

Phillip, Australian Capital Territory, Australia

Momentum Clinical Research /ID# 254411

Darlinghurst, New South Wales, Australia

Skin Health Institute Inc /ID# 254416

Carlton, Victoria, Australia

Sinclair Dermatology - Melbourne /ID# 254412

East Melbourne, Victoria, Australia

The Alfred Hospital /ID# 254414

Melbourne, Victoria, Australia

Medizinische Universitaet Wien /ID# 254096

Vienna, State of Vienna, Austria

And 185 more locations on ClinicalTrials.gov